Polyneuropathy (peripheral)

Alphabetical Index

Use the alphabetical index for the main term polyneuropathy (peripheral) to review the available sub terms and properly select the ICD-10 code with the highest degree of specificity. Instructional notations will guide the coder with information such as "see", "see also", "with", "without", "due to", and "code by site".

  • Polyneuropathy (peripheral) - G62.9 Polyneuropathy, unspecified
    • alcoholic - G62.1 Alcoholic polyneuropathy
    • amyloid (Portuguese) - E85.1 Neuropathic heredofamilial amyloidosis
    • arsenical - G62.2 Polyneuropathy due to other toxic agents
    • critical illness - G62.81 Critical illness polyneuropathy
    • demyelinating, chronic inflammatory (CIDP) - G61.81 Chronic inflammatory demyelinating polyneuritis
    • diabetic - See: Diabetes, polyneuropathy;
    • drug-induced - G62.0 Drug-induced polyneuropathy
    • hereditary - G60.9 Hereditary and idiopathic neuropathy, unspecified
      • specified NEC - G60.8 Other hereditary and idiopathic neuropathies
    • idiopathic - G60.9 Hereditary and idiopathic neuropathy, unspecified
      • progressive - G60.3 Idiopathic progressive neuropathy
    • in (due to)
      • alcohol - G62.1 Alcoholic polyneuropathy
        • sequelae - G65.2 Sequelae of toxic polyneuropathy
      • amyloidosis, familial (Portuguese) - E85.1 Neuropathic heredofamilial amyloidosis
      • antitetanus serum - G61.1 Serum neuropathy
      • arsenic - G62.2 Polyneuropathy due to other toxic agents
        • sequelae - G65.2 Sequelae of toxic polyneuropathy
      • avitaminosis NEC - E56.9 Vitamin deficiency, unspecified
      • beriberi - E51.11 Dry beriberi
      • collagen vascular disease NEC - M35.9 Systemic involvement of connective tissue, unspecified
      • deficiency (of)
        • B (-complex) vitamins - E53.9 Vitamin B deficiency, unspecified
        • vitamin B6 - E53.1 Pyridoxine deficiency
      • diabetes - See: Diabetes, polyneuropathy;
      • diphtheria - A36.83 Diphtheritic polyneuritis
      • drug or medicament - G62.0 Drug-induced polyneuropathy
        • correct substance properly administered - See: Table of Drugs and Chemicals, by drug, adverse effect;
        • overdose or wrong substance given or taken - See: Table of Drugs and Chemicals, by drug, poisoning;
      • endocrine disease NEC - E34.9 Endocrine disorder, unspecified
      • herpes zoster - B02.23 Postherpetic polyneuropathy
      • hypoglycemia - E16.2 Hypoglycemia, unspecified
      • infectious
        • disease NEC - B99 Other and unspecified infectious diseases
        • mononucleosis - B27.91 Infectious mononucleosis, unspecified with polyneuropathy
      • lack of vitamin NEC - E56.9 Vitamin deficiency, unspecified
      • lead - G62.2 Polyneuropathy due to other toxic agents
        • sequelae - G65.2 Sequelae of toxic polyneuropathy
      • leprosy - A30.9 Leprosy, unspecified
      • Lyme disease - A69.22 Other neurologic disorders in Lyme disease
      • metabolic disease NEC - E88.9 Metabolic disorder, unspecified
      • microscopic polyangiitis - M31.7 Microscopic polyangiitis
      • mumps - B26.84 Mumps polyneuropathy
      • neoplastic disease - See Also: Neoplasm; - D49.9 Neoplasm of unspecified behavior of unspecified site
      • nutritional deficiency NEC - E63.9 Nutritional deficiency, unspecified
      • organophosphate compounds - G62.2 Polyneuropathy due to other toxic agents
        • sequelae - G65.2 Sequelae of toxic polyneuropathy
      • parasitic disease NEC - B89 Unspecified parasitic disease
      • pellagra - E52 Niacin deficiency [pellagra]
      • polyarteritis nodosa - M30.0 Polyarteritis nodosa
      • porphyria - E80.20 Unspecified porphyria
      • radiation - G62.82 Radiation-induced polyneuropathy
      • rheumatoid arthritis - See: Rheumatoid, polyneuropathy;
      • sarcoidosis - D86.89 Sarcoidosis of other sites
      • serum - G61.1 Serum neuropathy
      • syphilis (late) - A52.15 Late syphilitic neuropathy
        • congenital - A50.43 Late congenital syphilitic polyneuropathy
      • systemic
        • connective tissue disorder - M35.9 Systemic involvement of connective tissue, unspecified
        • lupus erythematosus - M32.19 Other organ or system involvement in systemic lupus erythematosus
      • toxic agent NEC - G62.2 Polyneuropathy due to other toxic agents
        • sequelae - G65.2 Sequelae of toxic polyneuropathy
    • inflammatory - G61.9 Inflammatory polyneuropathy, unspecified
      • chronic demyelinating (CIDP) - G61.81 Chronic inflammatory demyelinating polyneuritis
      • sequelae - G65.1 Sequelae of other inflammatory polyneuropathy
      • specified NEC - G61.89 Other inflammatory polyneuropathies
    • lead - G62.2 Polyneuropathy due to other toxic agents
      • sequelae - G65.2 Sequelae of toxic polyneuropathy
    • nutritional NEC - E63.9 Nutritional deficiency, unspecified
    • postherpetic (zoster) - B02.23 Postherpetic polyneuropathy
    • progressive - G60.3 Idiopathic progressive neuropathy
    • radiation-induced - G62.82 Radiation-induced polyneuropathy
    • sensory (hereditary) (idiopathic) - G60.8 Other hereditary and idiopathic neuropathies
    • specified NEC - G62.89 Other specified polyneuropathies
    • syphilitic (late) - A52.15 Late syphilitic neuropathy
      • congenital - A50.43 Late congenital syphilitic polyneuropathy

Clinical Terms

The following are some of the clinical term definitions related or applicable to polyneuropathy (peripheral) within the ICD-10 index for Diseases and Injuries.

Alcoholics: Persons who have a history of physical or psychological dependence on ETHANOL.

Arsenic: A shiny gray element with atomic symbol As, atomic number 33, and atomic weight 75. It occurs throughout the universe, mostly in the form of metallic arsenides. Most forms are toxic. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), arsenic and certain arsenic compounds have been listed as known carcinogens. (From Merck Index, 11th ed)

Beriberi: A disease caused by a deficiency of thiamine (vitamin B1) and characterized by polyneuritis, cardiac pathology, and edema. The epidemic form is found primarily in areas in which white (polished) rice is the staple food, as in Japan, China, the Philippines, India, and other countries of southeast Asia. (Dorland, 27th ed)

Diphtheria: A localized infection of mucous membranes or skin caused by toxigenic strains of CORYNEBACTERIUM DIPHTHERIAE. It is characterized by the presence of a pseudomembrane at the site of infection. DIPHTHERIA TOXIN, produced by C. diphtheriae, can cause myocarditis, polyneuritis, and other systemic toxic effects.

Herpes Zoster: An acute infectious, usually self-limited, disease believed to represent activation of latent varicella-zoster virus (HERPESVIRUS 3, HUMAN) in those who have been rendered partially immune after a previous attack of CHICKENPOX. It involves the SENSORY GANGLIA and their areas of innervation and is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area. (From Dorland, 27th ed)

Hypoglycemia: A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH.

Lead: A soft, grayish metal with poisonous salts; atomic number 82, atomic weight 207.2, symbol Pb.

Leprosy: A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid.

Lyme Disease: An infectious disease caused by a spirochete, BORRELIA BURGDORFERI, which is transmitted chiefly by Ixodes dammini (see IXODES) and pacificus ticks in the United States and Ixodes ricinis (see IXODES) in Europe. It is a disease with early and late cutaneous manifestations plus involvement of the nervous system, heart, eye, and joints in variable combinations. The disease was formerly known as Lyme arthritis and first discovered at Old Lyme, Connecticut.

Mumps: An acute infectious disease caused by RUBULAVIRUS, spread by direct contact, airborne droplet nuclei, fomites contaminated by infectious saliva, and perhaps urine, and usually seen in children under the age of 15, although adults may also be affected. (From Dorland, 28th ed)

Pellagra: A disease due to deficiency of NIACIN, a B-complex vitamin, or its precursor TRYPTOPHAN. It is characterized by scaly DERMATITIS which is often associated with DIARRHEA and DEMENTIA (the three D's).

Polyarteritis Nodosa: A form of necrotizing non-granulomatous inflammation occurring primarily in medium-sized ARTERIES, often with microaneurysms. It is characterized by muscle, joint, and abdominal pain resulting from arterial infarction and scarring in affected organs. Polyarteritis nodosa with lung involvement is called CHURG-STRAUSS SYNDROME.

Porphyrias: A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues.

Radiation: Emission or propagation of acoustic waves (SOUND), ELECTROMAGNETIC ENERGY waves (such as LIGHT; RADIO WAVES; GAMMA RAYS; or X-RAYS), or a stream of subatomic particles (such as ELECTRONS; NEUTRONS; PROTONS; or ALPHA PARTICLES).

Sarcoidosis: An idiopathic systemic inflammatory granulomatous disorder comprised of epithelioid and multinucleated giant cells with little necrosis. It usually invades the lungs with fibrosis and may also involve lymph nodes, skin, liver, spleen, eyes, phalangeal bones, and parotid glands.

Serum: The clear portion of BLOOD that is left after BLOOD COAGULATION to remove BLOOD CELLS and clotting proteins.

Tuberculosis: Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS.

Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.

Vitamin B 6: VITAMIN B 6 refers to several PICOLINES (especially PYRIDOXINE; PYRIDOXAL; & PYRIDOXAMINE) that are efficiently converted by the body to PYRIDOXAL PHOSPHATE which is a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, and aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into PYRIDOXAMINE phosphate. Although pyridoxine and Vitamin B 6 are still frequently used as synonyms, especially by medical researchers, this practice is erroneous and sometimes misleading (EE Snell; Ann NY Acad Sci, vol 585 pg 1, 1990). Most of vitamin B6 is eventually degraded to PYRIDOXIC ACID and excreted in the urine.